E3 PreliminaryPreliminaryPEM requiredReview-NarrativePeer-reviewedMachine draft
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
Morris, Gerwyn, Maes, Michael · BMC medicine · 2013 · DOI
Quick Summary
This review compares ME/CFS with multiple sclerosis (MS), another recognized neurological disease, and found striking similarities between them. Both conditions cause severe fatigue that worsens with exercise, autonomic problems (like dizziness and heart rate issues), and involve similar patterns of immune system activation and mitochondrial dysfunction (problems with how cells produce energy). The study suggests ME/CFS should be recognized as a genuine neuroimmune illness, similar to MS.
Why It Matters
This systematic comparison provides scientific evidence that ME/CFS shares biological mechanisms with MS, a recognized neurological disease. For patients, this supports the legitimacy of ME/CFS as a medical condition deserving equivalent research funding and clinical recognition. For researchers, it identifies specific biological pathways and mechanisms worthy of investigation.
Observed Findings
- Severe disabling fatigue and post-exercise symptom worsening occur in both ME/CFS and MS patients
- Autonomic dysfunction including orthostatic intolerance and abnormal cardiac responses to exercise are present in both conditions
- Activated immune pathways, oxidative/nitrosative stress, and similar patterns of autoantibodies are found in both illnesses
- Mitochondrial dysfunction characterized by reduced ATP, decreased phosphocreatine synthesis, and impaired oxidative phosphorylation occurs in both disorders
- Neuroimaging studies show similar abnormalities: decreased cerebral blood flow, gray matter reduction, white matter changes, and abnormal metabolite levels in both conditions
Inferred Conclusions
- ME/CFS and MS demonstrate remarkable phenomenological and neuroimmune similarities, suggesting both are legitimately classified as neuroimmune disorders
- The overlapping biological mechanisms, particularly immune activation and mitochondrial dysfunction, indicate these conditions may share common pathophysiological pathways
- ME/CFS should be recognized as a neurological disease with demonstrable biological markers rather than a psychiatric condition
- Patients with MS appear immunologically primed to develop ME/CFS-like symptoms
Remaining Questions
What This Study Does Not Prove
This review does not prove that ME/CFS and MS are the same disease, nor does it establish causal relationships between the identified biological abnormalities and symptoms. The similarities observed may reflect convergent pathological processes rather than shared etiology. Additionally, finding similar immune and mitochondrial markers does not explain why patients develop one condition versus the other.
Tags
Symptom:Post-Exertional MalaiseCognitive DysfunctionOrthostatic IntoleranceFatigue
Biomarker:MetabolomicsAutoantibodiesNeuroimagingBlood Biomarker
Phenotype:Infection-Triggered
Method Flag:Weak Case Definition
Metadata
- DOI
- 10.1186/1741-7015-11-205
- PMID
- 24229326
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →